CVS Stock Analysis: Buy, Sell, or Hold?
CVS - CVS HEALTH CORPORATION
$70.14
0.06 (0.09%)
▲
5d:
-1.61%
30d:
-12.22%
90d:
-11.9%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
CVS is down 3.1% this week, but smart money is accumulating calls. Top strike: $80 2026-04-17 with 10,870 OI. Call ratio: 62% View Scanner →
Strength: 2.7/10
Get Alerted When CVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CVS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CVS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$129.58
Based on 9.0% avg growth
INTRINSIC VALUE TODAY
$80.46
12.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CVS is currently trading at $70.14, which is considered oversold relative to its 30-day fair value range of $72.31 to $78.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.6) compared to its historical average (10.3). Remarkably, the market is currently pricing in an annual earnings decline of 5.9% over the next few years. This pessimistic expectation contrasts with the company's recent 76.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CVS is in a downtrend. The price is currently testing key support at $69.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CVS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $96.50 (+37.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CVS is in a downtrend. The price is currently testing key support at $69.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CVS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $96.50 (+37.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$72.31 -
$78.82
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding CVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.6% below Wall St target ($96.50)
Fair Price Analysis
30-Day Fair Range
$72.31 -
$78.82
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$69.67
Resistance Level
$76.62
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.57
Wall Street Target
$96.50
(+37.6%)
Revenue Growth (YoY)
8.4%
Earnings Growth (YoY)
76.6%
Profit Margin
0.4%
Valuation Discount vs History
-5.9% cheaper
PE vs Historical
8.6 vs 10.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.9%
(market-implied from PE analysis)
1-Year Target
$66.00
(-6%)
2-Year Target
$62.11
(-12%)
3-Year Target
$58.44
(-17%)
3-Yr Target (if PE normalizes)
(PE: 9→10)
$70.20
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 14.1%)
$271.71
(+287%)
Base:
(SPY PE: 8.6, Growth: 14.1%)
$104.25
(+49%)
Bear:
(PE: 7.3, Growth: 14.1%)
$88.61
(+26%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Forward PE: 9.98 | Forward EPS (Implied): $7.14
Bull Case
$86.08
(+21%)
Analyst growth 15.0%, PE expands to 10.5
Base Case
$71.29
(0%)
Market implied 0.0%, PE stable at 10.0
Bear Case
$54.54
(-24%)
Severe decline -15.0%, PE contracts to 9.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.6 to 10.3
Stabilization Target:
$84.25
(+20.1%)
PE Expansion Potential:
+20.1%
Share & Embed Analysis
Last updated: March 31, 2026 12:13 AM ET
Data refreshes hourly during market hours. Next update: 1:13 AM
Data refreshes hourly during market hours. Next update: 1:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVS showing a specific setup today?
Insider Activity (6 Months)
3
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-24
Michael T. McCaul
BUY
2026-02-20
John Boozman
BUY
2026-01-29
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$339 | 59 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$361 | 49 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$381 | 62 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$212 | 61 BUY |
|
CNC
Centene Corp |
BUY
19 analysts |
$43 | 45 HOLD |
Advanced CVS Option Strategies
Professional options setups generated by AI based on today's CVS price and gamma walls.
